Beckley PsytechBiotechnology1 / 15Read in the app

Pitch deck

Beckley Psytech's pitch deck

The deck, and the 3 rounds we watched Beckley Psytech raise afterwards, with the investors each report named.

Beckley Psytech is a clinical-stage biotechnology company that explores the therapeutic potential of psychedelic substances.

15 slides4.0MBGBBiotechnology

Read the deckFree account. The deck belongs to Beckley Psytech, so reading it needs one; everything on this page is public.

What is in it

The deck, slide by slide

Each slide by what it argues. 15 slides against a median of 13 across the 1,712 decks we hold.

median
  1. 1Cover
  2. 2Vision
  3. 3Validation
  4. 4Vision
  5. 5Product
  6. 6Team
  7. 7
  8. 8Problem
  9. 9Market
  10. 10
  11. 11Problem
  12. 12
  13. 13Product
  14. 14Team
  15. 15Contact

CoverVisionValidationProductTeamProblemMarketContact

  1. Nov 2025

    Round$2.9M

    No investor was named in the report.

    Source recorded

  2. Jan 2024
  3. Jul 2021

    Round$80M

    No investor was named in the report.

    Source recorded

Everyone who backed Beckley Psytech

Beckley Psytech pitch deck, cover slide1 / 15

The deck itself

Read Beckley Psytech's full pitch deck

All 15 slides, each read for what it argues and set against the decks that raised at the same stage. The cover is shown here; the rest is read in the app.

Read the deck →Free account. The deck belongs to Beckley Psytech.

Investors who claim them

Firms listing Beckley Psytech on their own portfolio page: the firm's own account rather than a round we watched. Weaker than an announcement, much stronger than a list somebody sold us.

More decks

Browse all 1,712 decks. We hold no record of where this file came from or on what terms. If it is yours and you would rather it were not here, tell us and it goes.